Abstract
Cao et al. introduce PANDA, an AI model designed for the early detection of pancreatic ductal adenocarcinoma (PDAC) using non-contrast CT scans. While the model shows great promise, it faces several challenges. Notably, its training predominantly on East Asian datasets raises concerns about generalizability across diverse populations. Additionally, PANDA's ability to detect rare lesions, such as pancreatic neuroendocrine tumors (PNETs), could be improved by integrating other imaging modalities. High specificity is a strength, but it also poses risks of false positives, which may lead to unnecessary procedures and increased healthcare costs. Implementing a tiered diagnostic approach and expanding training data to include a wider demographic are essential steps for enhancing PANDA's clinical utility and ensuring its successful global implementation, ultimately shifting the focus from late diagnosis to proactive early detection.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
